Susquehanna International Group’s Health Catalyst HCAT Stock Holding History

Susquehanna International Group’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$66.9K	Buy	+52,700	New	+$99.1K	﹤0.01%	12535
2025 Q2	–	Sell	-16,000	Closed	-$72.5K	–	13075
2025 Q1	$72.5K	Buy	16,000 +700	+5%	+$3.7K	﹤0.01%	11727
2024 Q4	$108K	Buy	+15,300	New	+$122K	﹤0.01%	11280
2022 Q4	–	Sell	-52,300	Closed	-$507K	–	12914
2022 Q3	$507K	Buy	+52,300	New	+$692K	﹤0.01%	8449
2021 Q4	–	Sell	-29,900	Closed	-$1.5M	–	13420
2021 Q3	$1.5M	Buy	29,900 +22,300	+293%	+$1.22M	﹤0.01%	6494
2021 Q2	$422K	Buy	7,600 +600	+9%	+$32K	﹤0.01%	9987
2021 Q1	$327K	Buy	+7,000	New	+$339K	﹤0.01%	10420
2020 Q4	–	Sell	-10,900	Closed	-$399K	–	11284
2020 Q3	$399K	Sell	10,900 -11,200	-51%	-$380K	﹤0.01%	8138
2020 Q2	$645K	Buy	+22,100	New	+$611K	﹤0.01%	6823

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

CDC Financial Chicago, Illinois $157M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return

PVM

Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Susquehanna International Group's HCAT Position: Q1 2026 in Review

Susquehanna International Group increased its Health Catalyst (HCAT) stake by 197% in Q1 2026, buying an estimated $101K and bringing the position to 81,154 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #12321.

Susquehanna International Group first reported a position in HCAT in Q1 2020 and has held it in 21 quarters since. The position peaked at $1.09M in Q3 2024. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

Susquehanna International Group held 81,154 shares of Health Catalyst worth $103K as of Q1 2026.
Susquehanna International Group bought 53,830 Health Catalyst shares in Q1 2026, an estimated $101K.
Health Catalyst made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12321 holding.
Susquehanna International Group first reported a position in Health Catalyst in Q1 2020 and has held it in 21 quarters since.
Susquehanna International Group's Health Catalyst position peaked at $1.09M in Q3 2024.
130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.